Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged AML
Mina Masoumeh Tayari, Helena Gomes Dos Santos, Felipe Beckedorff, Tulasigeri M. Totiger, Adnan Kasim Mookhtiar, Anna Lesley Kingham, Guilherme Miura Lavezzo, Glòria Mas Martín, Hsuan-Ting Huang, Efe Karaca, Daniel Bilbao, Justin Taylor, Ramin Shiekhattar, Justin M. Watts
This study identifies LSD1 as a cofactor of the menin-MLL-LEDGF complex and shows that combining menin and LSD1 inhibition effectively treats MLL-rearranged AML by dismantling oncogenic programs and promoting differentiation.
bioRxiv · Oct 13, 2025 · PreprintCancer Biology